Tom Nolan reviews this week’s research There’s certainly a gap in the market for an effective third or fourth line antihypertensive. A trial of lorundrostat, an aldosterone synthase inhibitor, found a ...

The study found that women have genes that help their hearts beat faster while men have gene networks that may lead to heart ...

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Miles ...

Heart failure patients at AdventHealth Lake Wales are taking control of their health and recovery outside of the hospital, ...

Cardioversion is a medical treatment used to reset an abnormal heart ... The procedure is used when heart rhythm disorders like atrial fibrillation, atrial flutter, or supraventricular tachycardia are ...

For decades, doctors and researchers have puzzled over a basic heart rhythm mystery: Why do women tend to have faster ...

Researchers sought to examine treatment satisfaction and relief of symptoms following self-administration of intranasal ...

The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton ...

A Jacksonville cardiologist weighs in on groundbreaking treatment for AFib and future innovations at Ascension St. Vincent's Riverside.

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.